Peng S, Chen Z, Wang J, Yu M, Niu X, Cui T
Adv Sci (Weinh). 2024; 12(7):e2409551.
PMID: 39731356
PMC: 11831444.
DOI: 10.1002/advs.202409551.
Kornienko A, Teplonogova M, Shevelyova M, Popkov M, Popov A, Ivanov V
J Funct Biomater. 2024; 15(12).
PMID: 39728173
PMC: 11676406.
DOI: 10.3390/jfb15120373.
Zhang Y, Qiu Y, Karimi A, Smith B
Eur J Nucl Med Mol Imaging. 2024; 52(4):1576-1595.
PMID: 39722062
PMC: 11849580.
DOI: 10.1007/s00259-024-07014-z.
Ma X, Jiang X, Wang Z, Fan Y, Li J, Chow C
Angew Chem Int Ed Engl. 2024; 64(7):e202419409.
PMID: 39535730
PMC: 11811689.
DOI: 10.1002/anie.202419409.
Liu S, Tian Y, Ye D
Chem Biomed Imaging. 2024; 2(1):1-3.
PMID: 39473460
PMC: 11504146.
DOI: 10.1021/cbmi.3c00118.
Ultraviolet (UV) radiation: a double-edged sword in cancer development and therapy.
Yu Z, Zheng M, Fan H, Liang X, Tang Y
Mol Biomed. 2024; 5(1):49.
PMID: 39417901
PMC: 11486887.
DOI: 10.1186/s43556-024-00209-8.
Treating Deep-Seated Tumors with Radiodynamic Therapy: Progress and Perspectives.
Zhu S, Lin S, Han R
Pharmaceutics. 2024; 16(9).
PMID: 39339173
PMC: 11435246.
DOI: 10.3390/pharmaceutics16091135.
Hypoxia makes EZH2 inhibitor not easy-advances of crosstalk between HIF and EZH2.
Huang Z, Tang Y, Zhang J, Huang J, Cheng R, Guo Y
Life Metab. 2024; 3(4.
PMID: 38911968
PMC: 11192520.
DOI: 10.1093/lifemeta/loae017.
Critical learning from industrial catalysis for nanocatalytic medicine.
Jin Z, Jiang L, He Q
Nat Commun. 2024; 15(1):3857.
PMID: 38719843
PMC: 11079063.
DOI: 10.1038/s41467-024-48319-9.
A pH-responsive nanoplatform with dual-modality imaging for enhanced cancer phototherapy and diagnosis of lung metastasis.
Yuan M, Han Z, Li Y, Zhan X, Sun Y, He B
J Nanobiotechnology. 2024; 22(1):180.
PMID: 38622591
PMC: 11017640.
DOI: 10.1186/s12951-024-02431-6.
FeO@TiO Microspheres: Harnessing O Release and ROS Generation for Combination CDT/PDT/PTT/Chemotherapy in Tumours.
Zhao B, Hu X, Chen L, Wu X, Wang D, Wang H
Nanomaterials (Basel). 2024; 14(6).
PMID: 38535646
PMC: 10974882.
DOI: 10.3390/nano14060498.
Multifunctional ZnO@DOX/ICG-LMHP Nanoparticles for Synergistic Multimodal Antitumor Activity.
Li Z, Wang J, Liu J, Yu J, Wang J, Wang H
J Funct Biomater. 2024; 15(2).
PMID: 38391888
PMC: 10889406.
DOI: 10.3390/jfb15020035.
Sustained and Localized Drug Depot Release Using Radiation-Activated Scintillating Nanoparticles.
Kang M, Quintana J, Hu H, Teixeira V, Olberg S, Banla L
Adv Mater. 2024; 36(23):e2312326.
PMID: 38389502
PMC: 11161319.
DOI: 10.1002/adma.202312326.
The use of nanomaterials in advancing photodynamic therapy (PDT) for deep-seated tumors and synergy with radiotherapy.
Dinakaran D, Wilson B
Front Bioeng Biotechnol. 2023; 11:1250804.
PMID: 37849983
PMC: 10577272.
DOI: 10.3389/fbioe.2023.1250804.
X-ray excited luminescent nanoparticles for deep photodynamic therapy.
Yao B, Liu X, Zhang W, Lu H
RSC Adv. 2023; 13(43):30133-30150.
PMID: 37849702
PMC: 10577683.
DOI: 10.1039/d3ra04984a.
Biosynthetic Melanin/Ce6-Based Photothermal and Sonodynamic Therapies Significantly Improved the Anti-Tumor Efficacy.
Yang Y, He Y, Zhou M, Fu M, Li X, Liu H
Pharmaceutics. 2023; 15(8).
PMID: 37631273
PMC: 10457960.
DOI: 10.3390/pharmaceutics15082058.
Precise manipulation of circadian clock using MnO nanocapsules to amplify photodynamic therapy for osteosarcoma.
Ge Y, Zhuang H, Zhang T, Liang H, Ding W, Zhou L
Mater Today Bio. 2023; 19:100547.
PMID: 36896415
PMC: 9988696.
DOI: 10.1016/j.mtbio.2023.100547.
Application of nanomedicine in radiotherapy sensitization.
Song X, Sun Z, Li L, Zhou L, Yuan S
Front Oncol. 2023; 13:1088878.
PMID: 36874097
PMC: 9977159.
DOI: 10.3389/fonc.2023.1088878.
Recent advances in lanthanide-doped up-conversion probes for theranostics.
Xu D, Li C, Li W, Lin B, Lv R
Front Chem. 2023; 11:1036715.
PMID: 36846851
PMC: 9949555.
DOI: 10.3389/fchem.2023.1036715.
X-ray Activated Nanoplatforms for Deep Tissue Photodynamic Therapy.
Souris J, Leoni L, Zhang H, Pan A, Tanios E, Tsai H
Nanomaterials (Basel). 2023; 13(4).
PMID: 36839041
PMC: 9962876.
DOI: 10.3390/nano13040673.